This document discusses the benefits of medical marijuana for seniors. It notes that over 13,000 seniors in BC alone are licensed to use medical marijuana for chronic conditions like pain, cancer, glaucoma, dementia, arthritis, and insomnia. As people age, their bodies absorb and metabolize drugs differently, causing medications to last longer with more side effects. Medical marijuana provides an alternative with fewer side effects than pharmaceuticals and can help reduce the number of prescription medications seniors take. The document reviews specific medical marijuana strains and administration methods and summarizes several research studies on its effectiveness for various illnesses common in seniors.
This document provides a guide for managing common symptoms in seriously ill pediatric patients, with a focus on end-of-life care. It outlines the social and medical aspects of accepting palliative care over curative treatment, maintaining comfort through active medical care, and managing a home or hospital death. The document also provides guidance on treating pain, nausea, anxiety, and other symptoms through pharmacological and non-pharmacological means.
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Roger Chou, MD, Associate Professor of Medicine for Oregon Health & Science University
and Director of Pacific Northwest Evidence-based Practice Center.
Principles for more cautious and selective opioid prescribing for chronic non...Group Health Cooperative
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Jane C. Ballantyne, MD FRCA, with the Department of Anesthesiology and Pain Medicine at UW Medicine.
Persistent pain is common in older adults and can cause functional impairment, falls, depression, decreased appetite, impaired sleep, and social isolation. The goal of pain treatment in the elderly is to reduce pain-related disability rather than just pain intensity and involves a multidisciplinary approach including patient education. Successful pain management requires an individualized approach considering physiological changes, comorbidities, and risks of drug interactions when selecting and dosing analgesics like acetaminophen, topical NSAIDs, opioids, and antineuropathic medications. Close monitoring is needed due to increased risk of side effects.
The document summarizes a national summit on opioid safety convened to develop consensus on safer opioid prescribing practices for chronic non-cancer pain. The summit goals were to: 1) develop consensus principles for more selective, cautious opioid use; 2) share approaches to mitigate risks; 3) share how to change practice and implement guidelines. It provided background on the opioid epidemic and research showing risks increasing with higher doses and limited evidence of long-term benefits. Draft principles for safer opioid prescribing included starting with non-opioid treatments, carefully evaluating risks, limiting dose escalation, and tapering patients off opioids when risks outweigh benefits.
CHRONIC PAIN AND DEPRESSION: Cause or Effect or Linked?Sudhir Kumar
Chronic pain and depression are both common conditions, and in many patients, they co-exist. This presentation looks at the link between chronic pain and depression. Various drugs that can be used to treat chronic pain/depression have been discussed, with a special emphasis on tricyclic antidepressants.
This document provides a guide for managing common symptoms in seriously ill pediatric patients, with a focus on end-of-life care. It outlines the social and medical aspects of accepting palliative care over curative treatment, maintaining comfort through active medical care, and managing a home or hospital death. The document also provides guidance on treating pain, nausea, anxiety, and other symptoms through pharmacological and non-pharmacological means.
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Roger Chou, MD, Associate Professor of Medicine for Oregon Health & Science University
and Director of Pacific Northwest Evidence-based Practice Center.
Principles for more cautious and selective opioid prescribing for chronic non...Group Health Cooperative
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Jane C. Ballantyne, MD FRCA, with the Department of Anesthesiology and Pain Medicine at UW Medicine.
Persistent pain is common in older adults and can cause functional impairment, falls, depression, decreased appetite, impaired sleep, and social isolation. The goal of pain treatment in the elderly is to reduce pain-related disability rather than just pain intensity and involves a multidisciplinary approach including patient education. Successful pain management requires an individualized approach considering physiological changes, comorbidities, and risks of drug interactions when selecting and dosing analgesics like acetaminophen, topical NSAIDs, opioids, and antineuropathic medications. Close monitoring is needed due to increased risk of side effects.
The document summarizes a national summit on opioid safety convened to develop consensus on safer opioid prescribing practices for chronic non-cancer pain. The summit goals were to: 1) develop consensus principles for more selective, cautious opioid use; 2) share approaches to mitigate risks; 3) share how to change practice and implement guidelines. It provided background on the opioid epidemic and research showing risks increasing with higher doses and limited evidence of long-term benefits. Draft principles for safer opioid prescribing included starting with non-opioid treatments, carefully evaluating risks, limiting dose escalation, and tapering patients off opioids when risks outweigh benefits.
CHRONIC PAIN AND DEPRESSION: Cause or Effect or Linked?Sudhir Kumar
Chronic pain and depression are both common conditions, and in many patients, they co-exist. This presentation looks at the link between chronic pain and depression. Various drugs that can be used to treat chronic pain/depression have been discussed, with a special emphasis on tricyclic antidepressants.
Complementary Therapies for Mesothelioma presented by Kathleen Wesa, MD, of Memorial Sloan-Kettering Cancer Center at the Mesothelioma Applied Research Foundation's conference in New York, NY on September 28, 2012. www.curemeso.org
INFLUENCE OF DEMOGRAPHIC FACTORS ON PAIN KILLER USAGE AND ADDICTION SYMPTOMSJing Zang
Pain killers have been a necessity for humans since their skin has been laden with pain receptors to signal them against any invasion or unusual going on in the body.This pain when exceeds the limits of tolerance has to be alleviated to reduce suffering. Since ancient times numerous natural substances like herbs and oils have been used to relieve pain, but in modern era more refined ways to relieve pain have been discovered that exactly target the precise pain. This research identifies the factors that govern painkiller usage and addiction and the people who, in majority fall prey to pleasures of pain killers. The research was carried out through a questionnaire and results were statistically analyzed by fishers exact test. Males, employed people, non medics and graduates are most attracted to pain killers and are susceptible to long term addiction. The reasons for these people falling prey to pain killers are work load, mental stress and physiological responses to the drug. These factors can be managed through proper intervention by health professionals. The role of friends and family too here cannot be ignored.
Peripheral neuropathy is a common condition, encountered by physicians as well as neurologists. However, a large number of challenges remain. These include difficulty in diagnosing, delay in diagnosis, investigations and lack of effective treatments. This presentation discusses these unmet needs and provides suggestions to overcome them.
Zonisamide is among the newer broad spectrum anti-epileptic drugs, effective against focal and generalized epilepsies. It can be taken once daily and is well tolerated. The current article focuses on clinical efficacy and safety of zonisamide in epilepsy (as add on or as monotherapy). There is long term data as well as comparative studies against carbamazepine.
This editorial discusses the author's changing views on long-term opioid treatment for non-cancer pain. While the author previously believed opioids were appropriate to treat all types of pain, the author now questions their effectiveness and safety for long-term treatment of non-cancer pain. The author describes commonly encountering patients on dangerously high opioid doses for musculoskeletal pain. The author argues guidelines setting a maximum recommended opioid dose could help address this problem.
This document discusses optimizing pain management in cancer treatment. It provides an overview of concepts like total pain, the WHO analgesic ladder for treating pain with opioids, and the importance of proper pain assessment and documentation. The key points are:
1) Total pain includes physical, psychosocial, emotional, and spiritual suffering experienced by cancer patients.
2) The WHO analgesic ladder recommends treating mild pain with non-opioids like paracetamol, moderate pain with weak opioids like codeine, and severe pain with strong opioids like morphine.
3) Proper pain assessment involves documenting pain scores, characteristics, causes, and impact on function to effectively guide pain treatment decisions.
Laura Mann Center Integrative Lecture Series: Fall 2014Cara Feldman-Hunt
The document discusses the history and impact of the Penny George Institute for Health and Healing (PGIHH) at Allina Health, an integrated health system in Minnesota. Key points:
1) PGIHH was founded in 2003 and is now the largest integrative health program integrated within a health system. It focuses on prevention, wellness, and lifestyle-related diseases.
2) Studies show PGIHH services significantly reduce patient pain, anxiety, and length of hospital stays. For example, oncology patients saw a 46.9% reduction in pain and 56.1% reduction in anxiety.
3) PGIHH aims to transform healthcare delivery through a holistic, preventative approach.
Palmitoylethanolamide in the Treatment of Neuropathic Pain Sudhir Kumar
Neuropathic pain is quite common. It is associated with severe disability and adversely affects the quality of life of sufferers. Current treatment options for neuropathic are not very effective. Moreover, they are associated with significant adverse effects. A new naturally occurring substance- PALMITOYLETHANOLAMIDE (PEA)- has been found to be effective and safe in treating neuropathic pain. The current presentation looks at the efficacy of PEA in neuropathic pain.
The document discusses strategies for managing sedation in neuro-ICU patients, including:
1) Titrating sedative and analgesic medications to keep patients calm, alert, and free of pain while being lightly sedated.
2) Using scales like the SAS and RASS to regularly assess sedation levels.
3) Preventing and identifying delirium using tools like the CAM-ICU, given its high prevalence in ICUs and association with poor outcomes.
4) Considering patient factors and medications when choosing a sedation regimen to balance safety, efficacy and risk of delirium.
In this presentation, we will discuss Chemotherapy Induced Peripheral Neuropathy with strict application of Evidence based medicine about the magnitude of the problem, how to diagnose, how to prevent and how to treat?
Chemotherapy Induced Peripheral Neuropathy (CIPN): A Song of Ice and FireChristopher B. Ralph
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting neurotoxic effect affecting many patients receiving chemotherapy, characterized by pain and loss of sensation in the hands and feet. It can interfere with cancer patients’ treatment and significantly reduce their quality of life. With better treatment options like new anti-emetics and hematopoietic colony stimulating factors for other serious side-effects, CIPN emerges more often as a dose limiting factor. In this session, we will discuss prevention, monitoring, pharmaceutical treatment options, as well as other modalities to consider. We will also explore future management options for this pervasive, debilitating adverse effect of cancer treatment.
Author: Twitter @ChrisRalphRx
This document discusses neuropathic pain, including its classification, signs and symptoms, diagnosis, and management. Some key points:
- Neuropathic pain arises from lesions or diseases affecting the somatosensory system and is often chronic in nature. Common causes include low back pain, diabetes, herpes zoster infections, and postsurgical pain.
- Both nociceptive and neuropathic pain components may co-exist in conditions like low back pain. Neuropathic pain is often described as burning, electric shock-like, or tingling and may occur in areas distant from the site of injury.
- Diagnosis involves listening to the patient's descriptions of their pain, locating areas of abnormal sensation, and looking for signs
opioids in cancer pain manage, a case-based approach, covering
- opioid dosing and rotations
- pain assessment
- opioids adverse effects and managment thereof
- overcoming barriers to usage
1 adequate therapy for chronic non cancer painPuya Arash
This document discusses chronic non-cancer pain (CNCP) and barriers to its treatment. It reviews the prevalence of CNCP, affecting over 25% of the population. Current therapeutic approaches include non-pharmacological measures, analgesics like opioids and tramadol, and invasive interventions. However, barriers remain for physicians, patients, and the healthcare system. The document calls for a multidisciplinary approach and changes to improve CNCP management.
This document discusses emerging pharmacological and non-pharmacological aspects in pain management. It notes that multimodal analgesia using combinations of drugs targeting different pain pathways can provide improved pain relief with reduced side effects compared to single drugs. Newer drugs targeting specific receptor subtypes are emerging. Non-invasive options such as topical agents, exercise, and interventional techniques are increasingly utilized before more invasive options. Interventional pain management techniques discussed include injections, neurolysis, and spinal cord stimulation.
Demystifying Opioid Rotations: The Phantom Menace or A New Hope Christopher B. Ralph
The document provides an overview of opioid rotation calculations and principles of opioid use in cancer pain management. It begins with objectives and a case study on a patient named Justin Payne who is experiencing insufficient pain control and adverse effects from morphine. The document then discusses principles of opioid initiation and use, breakthrough pain, adverse effects, opioid rotation calculations using equianalgesic dosing, limitations of equianalgesic charts, and converting to transdermal fentanyl. Options discussed for Justin Payne include addressing possible opioid-induced neurotoxicity, adding an adjuvant, or rotating to another opioid like hydromorphone or transdermal fentanyl.
The future: Presentation by Gavin GiovannoniMS Trust
This document summarizes information from a presentation on multiple sclerosis (MS). It begins with disclosures from the presenter regarding compensation received from pharmaceutical companies. It then provides images and diagrams on various topics related to MS, including: cortical lesions; brain atrophy across disease stages; remyelination pathways and targets like LINGO-1; and study designs testing potential neuroprotective and remyelinating agents. One study examines the drug phenytoin in acute optic neuritis to assess neuroprotection by measuring retinal nerve fiber layer thickness. In summary, the document reviews MS pathology and potential new therapeutic strategies targeting remyelination and neuroprotection that are being investigated in clinical trials.
Medical marijuana's benefits for non smokersSophia Moore
The fact that many people are using cannabis to their benefits is undeniable, however there are still a lot of non-smokers, who consider Cannabis to be harmful. This presentation will show the benefits of Medical Marijuana and its effects on various diseases.
This document provides information about various psychiatric medications, including their purposes, common types, potential side effects, and precautions. It discusses medications used to treat psychosis (antipsychotics), side effects of antipsychotics, mood disorders (lithium, anticonvulsants), depression (SSRIs, tricyclics, MAOIs). Key points covered include the importance of adherence, monitoring side effects, blood tests where needed, and discussing any other medications or substances with doctors due to potential interactions.
Complementary Therapies for Mesothelioma presented by Kathleen Wesa, MD, of Memorial Sloan-Kettering Cancer Center at the Mesothelioma Applied Research Foundation's conference in New York, NY on September 28, 2012. www.curemeso.org
INFLUENCE OF DEMOGRAPHIC FACTORS ON PAIN KILLER USAGE AND ADDICTION SYMPTOMSJing Zang
Pain killers have been a necessity for humans since their skin has been laden with pain receptors to signal them against any invasion or unusual going on in the body.This pain when exceeds the limits of tolerance has to be alleviated to reduce suffering. Since ancient times numerous natural substances like herbs and oils have been used to relieve pain, but in modern era more refined ways to relieve pain have been discovered that exactly target the precise pain. This research identifies the factors that govern painkiller usage and addiction and the people who, in majority fall prey to pleasures of pain killers. The research was carried out through a questionnaire and results were statistically analyzed by fishers exact test. Males, employed people, non medics and graduates are most attracted to pain killers and are susceptible to long term addiction. The reasons for these people falling prey to pain killers are work load, mental stress and physiological responses to the drug. These factors can be managed through proper intervention by health professionals. The role of friends and family too here cannot be ignored.
Peripheral neuropathy is a common condition, encountered by physicians as well as neurologists. However, a large number of challenges remain. These include difficulty in diagnosing, delay in diagnosis, investigations and lack of effective treatments. This presentation discusses these unmet needs and provides suggestions to overcome them.
Zonisamide is among the newer broad spectrum anti-epileptic drugs, effective against focal and generalized epilepsies. It can be taken once daily and is well tolerated. The current article focuses on clinical efficacy and safety of zonisamide in epilepsy (as add on or as monotherapy). There is long term data as well as comparative studies against carbamazepine.
This editorial discusses the author's changing views on long-term opioid treatment for non-cancer pain. While the author previously believed opioids were appropriate to treat all types of pain, the author now questions their effectiveness and safety for long-term treatment of non-cancer pain. The author describes commonly encountering patients on dangerously high opioid doses for musculoskeletal pain. The author argues guidelines setting a maximum recommended opioid dose could help address this problem.
This document discusses optimizing pain management in cancer treatment. It provides an overview of concepts like total pain, the WHO analgesic ladder for treating pain with opioids, and the importance of proper pain assessment and documentation. The key points are:
1) Total pain includes physical, psychosocial, emotional, and spiritual suffering experienced by cancer patients.
2) The WHO analgesic ladder recommends treating mild pain with non-opioids like paracetamol, moderate pain with weak opioids like codeine, and severe pain with strong opioids like morphine.
3) Proper pain assessment involves documenting pain scores, characteristics, causes, and impact on function to effectively guide pain treatment decisions.
Laura Mann Center Integrative Lecture Series: Fall 2014Cara Feldman-Hunt
The document discusses the history and impact of the Penny George Institute for Health and Healing (PGIHH) at Allina Health, an integrated health system in Minnesota. Key points:
1) PGIHH was founded in 2003 and is now the largest integrative health program integrated within a health system. It focuses on prevention, wellness, and lifestyle-related diseases.
2) Studies show PGIHH services significantly reduce patient pain, anxiety, and length of hospital stays. For example, oncology patients saw a 46.9% reduction in pain and 56.1% reduction in anxiety.
3) PGIHH aims to transform healthcare delivery through a holistic, preventative approach.
Palmitoylethanolamide in the Treatment of Neuropathic Pain Sudhir Kumar
Neuropathic pain is quite common. It is associated with severe disability and adversely affects the quality of life of sufferers. Current treatment options for neuropathic are not very effective. Moreover, they are associated with significant adverse effects. A new naturally occurring substance- PALMITOYLETHANOLAMIDE (PEA)- has been found to be effective and safe in treating neuropathic pain. The current presentation looks at the efficacy of PEA in neuropathic pain.
The document discusses strategies for managing sedation in neuro-ICU patients, including:
1) Titrating sedative and analgesic medications to keep patients calm, alert, and free of pain while being lightly sedated.
2) Using scales like the SAS and RASS to regularly assess sedation levels.
3) Preventing and identifying delirium using tools like the CAM-ICU, given its high prevalence in ICUs and association with poor outcomes.
4) Considering patient factors and medications when choosing a sedation regimen to balance safety, efficacy and risk of delirium.
In this presentation, we will discuss Chemotherapy Induced Peripheral Neuropathy with strict application of Evidence based medicine about the magnitude of the problem, how to diagnose, how to prevent and how to treat?
Chemotherapy Induced Peripheral Neuropathy (CIPN): A Song of Ice and FireChristopher B. Ralph
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting neurotoxic effect affecting many patients receiving chemotherapy, characterized by pain and loss of sensation in the hands and feet. It can interfere with cancer patients’ treatment and significantly reduce their quality of life. With better treatment options like new anti-emetics and hematopoietic colony stimulating factors for other serious side-effects, CIPN emerges more often as a dose limiting factor. In this session, we will discuss prevention, monitoring, pharmaceutical treatment options, as well as other modalities to consider. We will also explore future management options for this pervasive, debilitating adverse effect of cancer treatment.
Author: Twitter @ChrisRalphRx
This document discusses neuropathic pain, including its classification, signs and symptoms, diagnosis, and management. Some key points:
- Neuropathic pain arises from lesions or diseases affecting the somatosensory system and is often chronic in nature. Common causes include low back pain, diabetes, herpes zoster infections, and postsurgical pain.
- Both nociceptive and neuropathic pain components may co-exist in conditions like low back pain. Neuropathic pain is often described as burning, electric shock-like, or tingling and may occur in areas distant from the site of injury.
- Diagnosis involves listening to the patient's descriptions of their pain, locating areas of abnormal sensation, and looking for signs
opioids in cancer pain manage, a case-based approach, covering
- opioid dosing and rotations
- pain assessment
- opioids adverse effects and managment thereof
- overcoming barriers to usage
1 adequate therapy for chronic non cancer painPuya Arash
This document discusses chronic non-cancer pain (CNCP) and barriers to its treatment. It reviews the prevalence of CNCP, affecting over 25% of the population. Current therapeutic approaches include non-pharmacological measures, analgesics like opioids and tramadol, and invasive interventions. However, barriers remain for physicians, patients, and the healthcare system. The document calls for a multidisciplinary approach and changes to improve CNCP management.
This document discusses emerging pharmacological and non-pharmacological aspects in pain management. It notes that multimodal analgesia using combinations of drugs targeting different pain pathways can provide improved pain relief with reduced side effects compared to single drugs. Newer drugs targeting specific receptor subtypes are emerging. Non-invasive options such as topical agents, exercise, and interventional techniques are increasingly utilized before more invasive options. Interventional pain management techniques discussed include injections, neurolysis, and spinal cord stimulation.
Demystifying Opioid Rotations: The Phantom Menace or A New Hope Christopher B. Ralph
The document provides an overview of opioid rotation calculations and principles of opioid use in cancer pain management. It begins with objectives and a case study on a patient named Justin Payne who is experiencing insufficient pain control and adverse effects from morphine. The document then discusses principles of opioid initiation and use, breakthrough pain, adverse effects, opioid rotation calculations using equianalgesic dosing, limitations of equianalgesic charts, and converting to transdermal fentanyl. Options discussed for Justin Payne include addressing possible opioid-induced neurotoxicity, adding an adjuvant, or rotating to another opioid like hydromorphone or transdermal fentanyl.
The future: Presentation by Gavin GiovannoniMS Trust
This document summarizes information from a presentation on multiple sclerosis (MS). It begins with disclosures from the presenter regarding compensation received from pharmaceutical companies. It then provides images and diagrams on various topics related to MS, including: cortical lesions; brain atrophy across disease stages; remyelination pathways and targets like LINGO-1; and study designs testing potential neuroprotective and remyelinating agents. One study examines the drug phenytoin in acute optic neuritis to assess neuroprotection by measuring retinal nerve fiber layer thickness. In summary, the document reviews MS pathology and potential new therapeutic strategies targeting remyelination and neuroprotection that are being investigated in clinical trials.
Medical marijuana's benefits for non smokersSophia Moore
The fact that many people are using cannabis to their benefits is undeniable, however there are still a lot of non-smokers, who consider Cannabis to be harmful. This presentation will show the benefits of Medical Marijuana and its effects on various diseases.
This document provides information about various psychiatric medications, including their purposes, common types, potential side effects, and precautions. It discusses medications used to treat psychosis (antipsychotics), side effects of antipsychotics, mood disorders (lithium, anticonvulsants), depression (SSRIs, tricyclics, MAOIs). Key points covered include the importance of adherence, monitoring side effects, blood tests where needed, and discussing any other medications or substances with doctors due to potential interactions.
The document discusses both the benefits and risks of weed (marijuana). It outlines several potential medical benefits of weed including relieving chronic pain and nausea, reducing seizures associated with epilepsy, improving appetite and reducing weight loss in HIV patients, and potentially reducing symptoms of anxiety, depression and PTSD. However, it also notes weed may exacerbate mental health conditions like psychosis and bipolar disorder. The document cautions that weed use during pregnancy may impact childhood development and health. Overall, it provides an overview of current research on both the potential medical advantages and disadvantages of weed.
There are various treatment methods for bipolar disorder, including; drug therapy, psychotherapy, mental health supplements and ect. http://mentalhealthlivingwithbipolar.blogspot.com/p/blog-page_27.html
This document discusses end-of-life care and palliative care. It notes that the majority of deaths in India occur in misery, and quality of death in India ranks poorly compared to other countries. Palliative care aims to improve quality of life for patients through effective pain and symptom management as well as psychosocial support. It discusses principles of palliative care including open communication, addressing total pain, use of opioids and other adjuvants for pain management, and withdrawal symptoms from opioids. The document also covers advance directives, best interest decisions, double effect, and when to stop life-prolonging treatment for terminally ill patients.
Cannabis has existed for over 3000 years, but we still lack high quality data on its efficacy and safety. It contains hundreds of compounds that work through the endocannabinoid system. While some evidence suggests it may help with nausea, appetite, and pain, the evidence is limited by small studies of poor quality. Adverse effects vary depending on dosage, route of administration, and individual factors, and can include anxiety, impaired memory, increased heart rate, immunosuppression, and psychosis with long term use. Due to drug interactions and long half-life, cannabis may interact with many medications in complex ways. More research is still needed to fully understand cannabis and develop it as a medicine.
Health Benefits of Cannabis You Should KnowDianaVicente6
For years, cannabis has held a negative stigma in society. However, as more and more states legalize it for medicinal and recreational use, people are beginning to see the many benefits of this plant. Here are just a few of the health benefits of cannabis you should know about.
Benefits of marijuana cannabis to chemotherapy (thesis)Daniel Bragais
This document discusses the benefits of marijuana for chemotherapy patients. It provides background on marijuana and its properties. Key points include:
- Marijuana contains THC which can help reduce nausea and vomiting from chemotherapy as well as ease other side effects.
- A case study is described of a woman named Leela whose health improved dramatically after being treated with cannabis oil for her cancer.
- The interviewee believes legalizing and regulating marijuana could help many cancer patients and create new jobs. However, some doctors remain skeptical due to cognitive biases and existing beliefs about pharmaceutical treatments.
Marijuana is a banned drug in many countries over the world. Although it is effective in treating nausea associated with chemotherapy as well as in increasing appetite in HIV patients. inspite of being useful in giving palliative care to terminal patients, marijuana is a banned drug in india and many other countries. This slide deals with the ethical issues in the medical use of marijuana.
This document discusses the use of medical marijuana to treat several severe or chronic conditions in Colorado patients. It outlines how marijuana has been shown to effectively treat severe chronic pain, muscle spasms, multiple sclerosis, nausea, cancer, epilepsy, glaucoma, and other conditions by reducing symptoms like pain, tremors, and spasms without the side effects of pharmaceutical drugs. The document also provides the fee structure for new patient certifications, renewals, and a package that includes all documents required to become a medical marijuana patient in Colorado.
Herbs and herbal remedies have been used for centuries to treat various ailments. The document discusses the history of herbal medicine and examines some popular herbs such as garlic, St. John's wort, and ginkgo biloba. While herbal remedies can provide health benefits, it is important to check with a certified herbalist or doctor due to potential side effects and drug interactions. Locating a certified herbalist through organizations like NCCAM or Mayo Clinic can help ensure safe and effective use of herbal supplements.
Prescription drugs are medications prescribed by doctors to treat medical conditions. There are three main types: opioids which relieve pain, stimulants that increase energy, and depressants that cause sedation. While prescription drugs can effectively treat conditions, they also carry risks of addiction, dependency, and overdose if misused. Long term misuse can lead to health issues like increased anxiety, breathing problems, and hostility. While prescription drugs are important for healthcare, their easy accessibility and potential for abuse require responsible use to avoid harmful consequences.
The document discusses the misuse of prescription stimulant drugs like Adderall. It notes that while prescription drugs can help with illnesses and needs when taken as prescribed, misuse by taking larger doses, someone else's medication, or for unintended purposes is problematic. Specifically, it outlines some of the negative health effects of misusing stimulants like increased blood pressure and risk of infectious diseases from needle sharing. Though stimulants can effectively treat conditions like ADHD when taken properly, repeated misuse can lead to side effects ranging from mild like skin issues to more severe like psychosis, aggression or seizures. In total, around 16 million US adults misuse prescription stimulants with potential for death or long term health complications.
Nutrition cancer wellness: integrative techniques for cancerAshwani Garg, MD
(1) A doctor discusses nutrition and lifestyle techniques for cancer wellness and prevention based on general principles from cancer organizations. Exercise, fiber-rich foods, stress management like mindfulness are recommended.
(2) One study found prostate cancer patients following a plant-based diet had reduced risk of disease progression compared to a non-treatment group.
(3) While more research is needed, some studies indicate cannabinoids, breast milk, and massage/yoga/acupuncture may provide benefits for cancer patients, but patients should discuss any treatments with their doctor.
Integrative medicine/oncology combines conventional cancer care with evidence-based complementary therapies to enhance quality of life for cancer patients. The document discusses the evolution of integrative medicine from alternative medicine to its current focus on patient-centered care and maximizing innate healing through mind-body practices, nutrition, and therapies like acupuncture and massage. It also emphasizes the importance of research to understand how complementary therapies can safely benefit patients and potentially synergize with conventional care.
Integrative medicine/oncology combines conventional cancer treatments with evidence-based complementary therapies to improve quality of life for cancer patients. The document discusses the evolution of integrative medicine from alternative medicine to its current focus on patient-centered care and maximizing innate healing through mind-body practices, nutrition, and therapies like acupuncture and massage. It also emphasizes the importance of research to understand how complementary therapies can safely benefit patients and identify potential drug interactions.
This document discusses palliative pain management in older adults. It defines palliative care and focuses on symptom management using a holistic interprofessional approach. It reviews pain assessment tools, types of pain, pharmacological and non-pharmacological management options, and common pitfalls in treating pain in older adults. Case examples are provided to demonstrate comprehensive pain assessments and developing individualized treatment plans.
Similar to Medical Marijuana Benefits for Seniors (20)
1. Medical Marijuana Benefits
for Seniors
Why They Benefit the Most
Presented by:
Robert Horning, B.Sc., R.P.
East West Science Ltd.
2. Seniors Using Medical Marijuana in BC
• According to data released by Health Canada
in December 2012, 13,362 seniors in B.C.
alone are licensed to possess medical
marijuana.
3. Their Reasoning for Using Medical
Marijuana
• By age of 65, seniors can have several different
chronic illnesses to manage every day including
• chronic pain
• cancer
• glaucoma
• dementia
• arthritis
• insomnia
4. • The traditional approach is to treat these
illnesses with pharmaceuticals.
• With cannabis, one medication for many
ailments, instead of
• Many medications from one condition, one for
the condition and others for side effects like
heartburn for sleeping meds, antidepressants
for the sleeping pills, etc.
7. ALTERED PHYSIOLOGIC VARIABLES IN
OLDER PATIENTS
Physiologic Variable Adults Elderly
1.) Absorption
Esophageal motility
Gastric emptying time (half
time, min)
47 123
Achlorhydria (incidence, %) 5 26
Muscle mass and blood flow
8. ALTERED PHYSIOLOGIC VARIABLES IN
OLDER PATIENTS
Physiologic Variable Adults Elderly
2.) Distribution
Serum albumin 4.7 3.8
Alpha-1 acid glycoprotein (mg/dL) 28 102
Total body water (L/kg weight) .50 .47
Adipose tissue (% total body weight)
Male 18 36
Female 33 45
10. What Does This Mean?
1.) Reduced Drug Absorption of Drugs
2.) Reduced Volume of Distribution of Drugs
3.) Decreased Metabolism of Drugs
4.) Reduced Elimination of Drugs
All these factors result in drugs lasting longer and
having a greater effect and more side effects in Seniors
than in Non-Seniors.
11. Plasma Half-Lives in Young and Old
Drug Young (20-30) Elderly (65-80)
Penicillin G 20.7 min 39.1 min
Tetracycline 3.5 hr 4.5 hr
Digoxin 51 hr 73 hr
Diazepam 20 hr 80 hr
Lidocaine 80.6 hr 139.6 hr
Chlordiazepoxide 8.9 hr 16.7 hr
Phenobarbital 71 hr 107 hr
Warfarin 37 hr 44 hr
12. A Few Things About
Medical Marijuana
That Seniors
Should Know
13. Marijuana is SAFER than prescription
medications
• According to the CDC, in 2008, 36,450 deaths were attributed
to prescription drug overdose.
• To date, not a single person has ever died from a marijuana
overdose.
• And the side effects of marijuana are minor in comparison to
the side effects of many prescription drugs. You will NEVER
see a warning such as, “This drug may increase the likelihood
of suicide or suicidal thoughts,” connected to marijuana.
Sadly, the same cannot be said for other medications.
14. Marijuana is not physically addictive
• Many seniors fear that if they start using marijuana they will
become addicted.
• Discontinuing the use of marijuana has much the same
response as quitting the consumption of coffee.
• Many people who seek welcome and effective respite from
chronic pain, anxiety, and stress use marijuana as a daily
medicine.
15. Marijuana can reduce and possibly
replace many prescription medications
• A major complaint of seniors regarding their daily medications
is that the first drug often causes side effects and a second
drug is then prescribed to fix it.
• Marijuana has the potential for accentuating the effect of
many commonly prescribed drugs. For example, opiate based
painkillers are typically enhanced when marijuana is used
concurrently, often resulting in a reduction of pharmaceutical
medicines.
• Marijuana’s healing properties target various conditions such
as inflamed joints, high blood pressure, chronic pain, digestive
disorders, constipation, headaches, insomnia, anxiety,
cognitive awareness, and more, eliminating many prescription
drugs.
16. There are thousands of marijuana strains
and they are good for different things
• One strain does not fit all. There are strains that are specific
for pain (Sativa) and strains that are targeted for insomnia
(Indica).
• Most of the seniors I talked to didn’t know the difference
between an Indica strain and a Sativa strain.
• An Indica is more sedating to the body and mind while a
Sativa is much more elevating and energizing.
• Even when one finds a marijuana strain that consistently
works for them, it can be advantageous for seniors to try
different strains because tolerance to the same strain has
been known to build up.
17. There are marijuana strains without
“the high”
• “If I could get the medical benefit marijuana without the
high, I’d consider it.” said many of the seniors we’ve spoken
to.
• Medical marijuana breeders have developed and are
currently producing potent CBD genetic strains that have
minimal psychoactive effect.
• CBD, or cannabidiol, is tremendous for inflammation, eases
pain, stimulates bone growth, suppresses muscular spasms,
reduces anxiety, and increases mental focus.
• These have proven extremely successful for persons
suffering from arthritis pain, nausea, and muscle spasms.
18.
19. There are ways to use marijuana other
than smoking it
• One common misconception among aging adults is that they have
to smoke marijuana to gain the medicinal benefits.
• The fact is that marijuana can be added to just about any regular
recipe in the form of cannabis infused butters or oils.
• There are also liquid extracts, syrups, lozenges, candies, chocolates,
etc. to choose from.
• Liquid extracts allow users to “titrate” or regulate their dose. In
other words, one can literally take the extract drop by drop every
ten minutes or so until they reach the point of physical or mental
relief they’re after.
• Vaporizing allows the user to inhale the cannabinoids without the
negative health effects associated with smoking.
20. Marijuana-infused ointments can be very
effective in alleviating arthritis and pain
• Locally made, medicated creams are very popular for sore
joints and muscles and back pain. They are very effective,
smell nice and give a you no “high” so you can feel
comfortable using the products throughout the day.
21. Marijuana does not lower your IQ or
cause brain damage
• Another common misconception aging adults have with
marijuana is that can lower intelligence or cause brain
damage .
• Studies with Alzheimer’s and Parkinson’s patients indicate
that marijuana gradually encourages new neural pathways,
allowing those with impaired brain function to potentially halt
further degeneration and even encourage brain function.
22. Medical Marijuana Studies for
Specific Illnesses
• chronic pain
• cancer
• glaucoma
• dementia
• arthritis
• insomnia
23. Chronic pain
• The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-
dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.
Eisenberg E, Ogintz M, Almog S. J Pain Palliat Care Pharmacother. 2014 Sep;28(3):216-25. doi:
10.3109/15360288.2014.941130. Epub 2014 Aug 13.
• The use of cannabis for management of chronic pain.
Bostwick JM. Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):2-3. doi:
10.1016/j.genhosppsych.2013.08.004. Epub 2013 Oct 1.
• Marijuana and chronic nonmalignant pain.
Harrison TE, Bruce BK, Weiss KE, Rummans TA, Bostwick JM. Mayo Clin Proc. 2013
Jul;88(7):647-50. doi: 10.1016/j.mayocp.2013.04.018. Epub 2013 Jun 17.
• The argument for medical marijuana for the treatment of chronic pain.
Carter GT. Pain Med. 2013 Jun;14(6):800. doi: 10.1111/pme.12137_2.
24. Cancer
• Cannabinoids as therapeutic agents in cancer: current status and future implications.
Chakravarti B, Ravi J, Ganju RK. Oncotarget. 2014 Aug 30;5(15):5852-72.
• Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia
chromosome mutation.
Singh Y, Bali C. Case Rep Oncol. 2013 Nov 28;6(3):585-92. doi: 10.1159/000356446.
eCollection 2013 Sep.
• Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content
of cannabidiol.
Romano B, Borrelli F, Pagano E, Cascio MG, Pertwee RG, Izzo AA. Phytomedicine. 2014 Apr
15;21(5):631-9. doi: 10.1016/j.phymed.2013.11.006. Epub 2013 Dec 25.
• Critical appraisal of the potential use of cannabinoids in cancer management.
Cridge BJ, Rosengren RJ. Cancer Manag Res. 2013 Aug 30;5:301-13. doi:
10.2147/CMAR.S36105. eCollection 2013. Review.
25. Glaucoma
• The use of marijuana to treat glaucoma.
Lederer CM. Mo Med. 2012 Mar-Apr;109(2):95. Review.
• Endocannabinoids in the retina: from marijuana to neuroprotection.
Yazulla S. Prog Retin Eye Res. 2008 Sep;27(5):501-26. doi: 10.1016/j.preteyeres.2008.07.002.
Epub 2008 Aug 3. Review.
• Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma.
Flach AJ. Trans Am Ophthalmol Soc. 2002;100:215-22; discussion 222-4.
• Cannabinoids in the treatment of glaucoma.
Järvinen T, Pate DW, Laine K. Pharmacol Ther. 2002 Aug;95(2):203-20. Review.
26. Dementia
• The multiplicity of action of cannabinoids: implications for treating neurodegeneration.
Gowran A, Noonan J, Campbell VA. CNS Neurosci Ther. 2011 Dec;17(6):637-44. doi:
10.1111/j.1755-5949.2010.00195.x. Epub 2010 Sep 28. Review.
• The role of phytochemicals in the treatment and prevention of dementia.
Howes MJ, Perry E. Drugs Aging. 2011 Jun 1;28(6):439-68. doi: 10.2165/11591310-
000000000-00000. Review.
• Cannabinoids for the treatment of dementia.
Krishnan S, Cairns R, Howard R. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007204. doi:
10.1002/14651858.CD007204.pub2. Review.
• Cannabinoids: novel medicines for the treatment of Huntington's disease.
Sagredo O, Pazos MR, Valdeolivas S, Fernandez-Ruiz J. Recent Pat CNS Drug Discov. 2012 Apr
1;7(1):41-8. Review.
27. Arthritis
• Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis.
Fukuda S, Kohsaka H, Takayasu A, Yokoyama W, Miyabe C, Miyabe Y, Harigai M, Miyasaka N, Nanki T.
BMC Musculoskelet Disord. 2014 Aug 12;15(1):275. doi: 10.1186/1471-2474-15-275.
• Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis
in MH7A human rheumatoid arthritis fibroblast-like synovial cells.
Jeong M, Cho J, Shin JI, Jeon YJ, Kim JH, Lee SJ, Kim ES, Lee K. J Ethnopharmacol. 2014 Jul
3;154(3):745-52. doi: 10.1016/j.jep.2014.04.052. Epub 2014 May 9.
• Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with
osteoarthritis and rheumatoid arthritis.
Richardson D, Pearson RG, Kurian N, Latif ML, Garle MJ, Barrett DA, Kendall DA, Scammell BE, Reeve
AJ, Chapman V. Arthritis Res Ther. 2008;10(2):R43. doi: 10.1186/ar2401. Epub 2008 Apr 16.
• The use of a cannabis-based medicine in the treatment of pain caused by rheumatoidarthritis.
Wright S, Ware M, Guy G. Rheumatology (Oxford). 2006 Jun;45(6):781; author reply 781-2. Epub
2006 Apr 18. No abstract available.
28. Insomnia
• The effects of cannabinoid administration on sleep: a systematic review of human studies.
Gates PJ, Albertella L, Copeland J. Sleep Med Rev. 2014 Mar 7. pii: S1087-0792(14)00021-5.
doi: 10.1016/j.smrv.2014.02.005. [Epub ahead of print] Review.
• Use of a cannabinoid in a correctional population for posttraumatic stress disorder-related
insomnia and nightmares, chronic pain, harm reduction, and other indications: a
retrospective evaluation.
Cameron C, Watson D, Robinson J. J Clin Psychopharmacol. 2014 Oct;34(5):559-64. doi:
10.1097/JCP.0000000000000180.
• The effects of cannabinoid administration on sleep: a systematic review of human studies.
Gates PJ, Albertella L, Copeland J. Sleep Med Rev. 2014 Mar 7. pii: S1087-0792(14)00021-5.
doi: 10.1016/j.smrv.2014.02.005. [Epub ahead of print] Review.
• Therapeutic benefits of cannabis: a patient survey.
Webb CW, Webb SM. Hawaii J Med Public Health. 2014 Apr;73(4):109-11.